about
Association of CCR5Δ32 and Behçet's disease: new data from a case-control study in the Spanish population and meta-analysis.The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients.Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish populationGenetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.Impact of episiotomy on the urogenital hiatus using transperineal ultrasound.Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.Palliative care and prognosis in COPD: a systematic review with a validation cohort.Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity.Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed.Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach.Variants of the IFI16 gene affecting the levels of expression of mRNA are associated with susceptibility to Behçet disease.Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.Lack of association of TNFAIP3 and JAK1 with Behçet's disease in the European population.Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.[Post-hospital mortality in patients re-admitted due to COPD. Utility of BODE index]Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.Systemic Expression of Cytokine Production in Patients with Severe Pneumococcal Pneumonia: Effects of Treatment with a β-Lactam versus a Fluoroquinolone.No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease.Does episiotomy protect against injury of the levator ani muscle in normal vaginal delivery?A logistic regression model predicting high axillary tumour burden in early breast cancer patients.Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention.Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index.Recent improvement in long-term survival after a COPD hospitalisation.
P50
Q30995534-A190886F-8BF4-4A7B-B707-5C4349D0243BQ31854771-59DFBAF5-AF58-429B-80C0-0DCF6F500FF4Q33895968-875D248A-F940-4804-B70A-A7E31C674E62Q36109098-DD045FCF-518B-4676-B86E-24067867C3F1Q36744785-97FADCBA-C839-4F2E-AACA-7C08012087B5Q37177435-6EE43165-3138-4DA0-ABB3-205234800E75Q38698316-CEDC4128-6B52-4D2A-8258-9FCCC514F075Q38734272-B7AA193C-AD27-4791-BA14-51AC1EEFB101Q38946780-940DBCDD-4567-4747-BA8F-91179E9FFE40Q39341671-7F457608-BB10-4905-BF4B-36A51EB5E9B2Q39399702-6BF81E63-78E7-45F4-9C74-A8CDA2F9B125Q39677035-2BE15796-A306-4316-ABA2-847349AD2471Q39800399-17BBEB76-A036-42C6-AAAC-8FC9703477BBQ39949717-D493045F-8BB1-4806-8272-911A4CF96F2DQ40067987-C06A56B1-8A2E-4D50-812E-1DC47BC5887EQ40182509-0831CA0D-2102-4431-BE5F-32627EFB8645Q40567310-3C5E2FF5-B110-41C9-9E7F-185A4889CDBEQ40717946-DC41DFD6-73D1-488B-AD11-B4406519ECCBQ40895161-DB0A1498-CAE6-4FD0-B07E-792EE99EE73BQ41102533-B3740B9B-DA55-496A-971F-ADB181132480Q41437263-961077D5-68F6-419C-9071-2E4E46446B71Q41510170-0C396C00-343C-4141-9127-E33D09F0AB5FQ41621778-1D62D8F3-0F81-4CF8-8259-EEC52D0BCC3AQ41719346-B2F7F160-8C7F-4B33-A9B7-9DA4B70FBE9DQ42648554-C3DF30B7-3908-42C4-B848-7FBE3A7A769CQ42997987-02EC0C0D-8751-47F0-A417-AB40E4B16329Q43815395-BDB90058-9905-48A5-A25C-5EBDC459FCCBQ44283837-D223B187-F169-4381-81A2-7B3A9CA3BD9BQ46618640-1E62D212-EBBB-4353-8E6F-084A5BE2F17DQ47443055-955766CF-6453-46FC-8B3E-29EB53E917D6Q47619122-8449FB03-0CF7-43D8-918F-8958F0369725Q47619131-D47CEC73-FFD3-4389-8254-73DCA4711F7EQ47730495-B0FA4B43-166F-471D-8374-77B5F3D9E72EQ47974027-2D8FC516-523E-4FD7-B94D-81993E3CA961Q48238273-31CA66C3-F594-44B7-8B85-7E67D38C3029Q49796667-BA0A2084-1C9D-4B72-8854-5FF4783AC6B9Q50059459-B476D217-E322-4514-8E0B-B68B2583698EQ50097908-D4300B99-53F3-45A6-BDC4-2DB390EF8E8AQ51611978-96591988-577C-4EBE-8CBD-4AB16AC3D1B0Q51774885-939DB767-61B1-4E31-B2E7-46F1DB46A47F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mónica Rodríguez Carballeira
@ast
Mónica Rodríguez Carballeira
@en
Mónica Rodríguez Carballeira
@es
Mónica Rodríguez Carballeira
@nl
type
label
Mónica Rodríguez Carballeira
@ast
Mónica Rodríguez Carballeira
@en
Mónica Rodríguez Carballeira
@es
Mónica Rodríguez Carballeira
@nl
prefLabel
Mónica Rodríguez Carballeira
@ast
Mónica Rodríguez Carballeira
@en
Mónica Rodríguez Carballeira
@es
Mónica Rodríguez Carballeira
@nl
P106
P1153
6602121721
P31
P496
0000-0002-8802-0238